Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Subgroup analysis for the evaluation the effect of following variables in the development of significant heterogeneity in the meta-analysis

From: The potential predictive value of miR-181 in women with preeclampsia: a systematic review and meta-analysis

Subgroup

Number of studies

SMD (95% CI)

P-value

Test of heterogeneity

    

I2%

P-value

Overall results

13

1.84 (0.47, 3.21)

0.008

98.06

0

Maternal age (year)

     

< 30

9

2.87 (0.68, 5.05)

0.01

98.05

0

≥ 30

4

-0.21 (-2.27,1.84)

0.83

97.7

0

Gestational age at delivery (week)

     

≤ 36

6

1.35 (-0.60, 3.3)

0.17

96.9

0

> 36

6

2.98 (0.58, 5.3)

0.015

97.7

0

Birth weight (g)

     

< 2500

2

4.68 (-0.06, 9.4)

0.05

92.1

0

> 2500

6

2.53 (0.71, 4.3)

0.006

96.7

0

Sample

     

Placenta

9

1.81 (-0.85, 4.4)

0.18

98.4

0

Body fluids (serum, plasma)

4

2.16 (0.84, 3.49)

0.001

96.6

0

Proteinuria (mg/24h)

     

≤ 300

2

6.02 (-1.6, 13.6)

0.12

98.1

0

> 300

5

-0.56 (-4.2, 3.1)

0.76

98.5

0

  1. SMD: Standardized mean difference, g: Gram, h: Hour,